Signaling potential adverse drug reactions from administrative health databases

Huidong Jin*, Jie Chen, Hongxing He, Chris Kelman, Damien Mcaullay, Christine M. O'keefe

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    42 Citations (Scopus)

    Abstract

    The work is motivated by real-world applications of detecting Adverse Drug Reactions (ADRs) from administrative health databases. ADRs are a leading cause of hospitalization and death worldwide. Almost all current postmarket ADR signaling techniques are based on spontaneous ADR case reports, which suffer from serious underreporting and latency. However, administrative health data are widely and routinely collected. They, especially linked together, would contain evidence of all ADRs. To signal unexpected and infrequent patterns characteristic of ADRs, we propose a domain-driven knowledge representation Unexpected Temporal Association Rule (UTAR), its interestingness measure, unexlev, and a mining algorithm MUTARA (Mining UTARs given the Antecedent). We then establish an improved algorithm, HUNT, for highlighting infrequent and unexpected patterns by comparing their ranks based on unexlev with those based on traditional leverage. Various experimental results on real-world data substantiate that both MUTARA and HUNT can signal suspected ADRs while traditional association mining techniques cannot. HUNT can reliably shortlist statistically significantly more ADRs than MUTARA (p=0.00078). HUNT, e.g., not only shortlists the drug alendronate associated with esophagitis as MUTARA does, but also shortlists alendronate with diarrhoea and vomiting for older (age ≥ 60) females. We also discuss signaling ADRs systematically by using HUNT.

    Original languageEnglish
    Article number5374401
    Pages (from-to)839-853
    Number of pages15
    JournalIEEE Transactions on Knowledge and Data Engineering
    Volume22
    Issue number6
    DOIs
    Publication statusPublished - 2010

    Fingerprint

    Dive into the research topics of 'Signaling potential adverse drug reactions from administrative health databases'. Together they form a unique fingerprint.

    Cite this